Table 2 Age- and stage-specific estimates of life expectancy, loss in life expectancy and proportion of expected life.

From: Understanding the impact of sex and stage differences on melanoma cancer patient survival: a SEER-based study

 

Localised

Regional

Distant

General population LE

LE (95% CI)

LEL (PELL %)

LE (95% CI)

LEL (PELL %)

LE (95% CI)

LEL (PELL %)

Age

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

40

35.22 (34.88–35.56)

40.69 (40.86–40.51)

0.70 (1.94)

0.17 (0.42)

22.96 (21.21–24.71)

32.72 (34.83–30.62)

12.96 (36.07)

8.14 (19.92)

10.29 (7.49–13.09)

19.89 (14.59–25.20)

25.62 (71.35)

20.97 (51.32)

35.92

40.86

50

26.93 (26.73–27.13)

31.74 (31.60–31.86)

0.46 (1.68)

0.16 (0.50)

18.60 (17.40–19.82)

25.43 (23.78–27.08)

8.78 (32.07)

6.47 (20.29)

8.87 (6.89–10.84)

15.02 (11.34–18.71)

18.52 (67.63)

16.88 (52.91)

27.39

31.90

60

19.70 (19.52–19.70)

23.60 (23.51–23.70)

0.25 (1.26)

0.13 (0.56)

14.87 (14.13–15.60)

18.94 (17.91–19.98)

4.99 (25.16)

4.79 (20.19)

8.13 (6.96–9.30)

11.12 (8.84–13.39)

11.73 (59.07)

12.62 (53.17)

19.86

23.74

70

13.56 (13.49–13.62)

16.33 (16.24–16.43)

0.19 (1.36)

0.13 (0.80)

10.11 (9.55–10.66)

12.31 (11.43–13.18)

3.64 (26.47)

4.15 (25.26)

5.12 (4.35–5.89)

6.28 (4.84–7.71)

8.62 (62.74)

10.19 (61.88)

13.74

16.47

80

8.31 (8.22–8.41)

10.02 (9.88–10.16)

0.24 (2.78)

0.18 (1.85)

4.83 (4.49–5.17)

5.80 (5.25–6.35)

3.72 (43.48)

4.40 (43.16)

1.56 (1.32–1.80)

1.99 (1.66–2.33)

6.99 (81.74)

8.21 (80.45)

8.55

10.20